About the Event
Nearly 40 million people suffer from some form of neuropathy and today the associated treatment costs exceed $4B. WinSanTor has developed the first-ever topical treatment that prevents and reverses nerve damage associated with neuropathy.
Join our webinar with WinSanTor CEO, Stanley Kim, as he discusses how their formulation can change the lives of people who suffer from the jarring pain and loss of feeling caused by neuropathy.